Microbot Medical Inc. (MBOT) — Financial statements
Income statement, balance sheet, and cash flow for Microbot Medical Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00↓100.0% | 0.09↓14.2% | 0.11 | 0.00 | 0.00 | |
| Gross Profit | 0.00↑100.0% | -0.09↑14.2% | -0.11 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 6↓5.2% | 7↑15.8% | 6↓26.0% | 8↑25.7% | 6 | |
| General & Administrative Expenses | 8↑65.1% | 5↑20.9% | 4↓26.0% | 6↑7.2% | 5 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.21 | |
| SG&A Expenses | 8↑65.1% | 5↑20.9% | 4↓26.0% | 6↑3.2% | 5 | |
| Other Expenses | 0.21↑334.1% | -0.09↑14.2% | -0.11↓194.4% | -0.04↑82.5% | -0.21 | |
| Operating Expenses | 15↑27.8% | 12↑18.3% | 10↓26.6% | 13↑16.9% | 11 | |
| Total Costs & Expenses | 15↑26.8% | 12↑18.0% | 10↓25.8% | 13↑16.9% | 11 | |
| Operating Results | ||||||
| Operating Income | -15↓26.8% | -12↓18.0% | -10↑25.8% | -13↓16.9% | -11 | |
| Depreciation & Amortization | 0.05↓48.4% | 0.09↓14.2% | 0.11↑3.9% | 0.10↑34.2% | 0.08 | |
| EBITDA | -15↓29.5% | -11↓6.8% | -11↑20.3% | -13↓18.2% | -11 | |
| EBIT | -15↓28.8% | -11↓6.5% | -11↑20.1% | -13↓18.3% | -11 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↓100.0% | 0.18↓20.2% | 0.23↑322.2% | 0.05↑22.7% | 0.04 | |
| Interest Income | 0.00↓100.0% | 0.18↓20.2% | 0.23↑322.2% | 0.05↑22.7% | 0.04 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -0.18↓120.6% | 0.89↑467.3% | 0.16 | 0.00 | |
| Other Income / Expenses | 2↑779.7% | 0.18↑120.6% | -0.89↓883.2% | 0.11↑156.8% | 0.04 | |
| Income Before Tax | -13↓14.8% | -11↓6.5% | -11↑18.4% | -13↓16.4% | -11 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -13↓14.8% | -11↓6.5% | -11↑18.4% | -13↓16.4% | -11 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -13↓14.8% | -11↓6.5% | -11↑18.4% | -13↓16.4% | -11 | |
| Bottom-Line Net Income | -13↓14.8% | -11↓6.5% | -11↑18.4% | -13↓16.4% | -11 | |
| EPS (Basic) | -0.29↑60.3% | -0.73↑30.5% | -1.05↑42.0% | -1.81↓13.8% | -1.59 | |
| EPS (Diluted) | -0.29↑60.3% | -0.73↑30.5% | -1.05↑42.0% | -1.81↓13.8% | -1.59 | |
| Weighted Average Shares | 46↑192.7% | 16↑53.4% | 10↑40.5% | 7↑2.1% | 7 | |
| Weighted Average Diluted Shares | 46↑192.7% | 16↑53.4% | 10↑40.5% | 7↑2.1% | 7 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.